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Reactive intermediates such as reactive nitrogen species play es-
sential roles in the cell as signaling molecules but, in excess, con-
stitute a major source of cellular damage. We found that nitrosative
stress induced by steady-state nitric oxide (NO) caused rapid acti-
vation of an ATM damage-response pathway leading to down-
stream signaling by this stress kinase to LKB1 and AMPK kinases,
and activation of the TSC tumor suppressor. As a result, in an ATM-,
LKB1-, TSC-dependent fashion, mTORC1 was repressed, as evi-
denced by decreased phosphorylation of S6K, 4E-BP1, and ULK1,
direct targets of the mTORC1 kinase. Decreased ULK1 phosphory-
lation by mTORC1 at S757 and activation of AMPK to phosphory-
late ULK1 at S317 in response to nitrosative stress resulted in
increased autophagy: the LC3-II/LC3-I ratio increased as did GFP-
LC3 puncta and acidic vesicles; p62 levels decreased in a lysosome-
dependent manner, conﬁrming an NO-induced increase in auto-
phagic ﬂux. Induction of autophagy by NO correlated with loss
of cell viability, suggesting that, in this setting, autophagy was
functioning primarily as a cytotoxic response to excess nitrosative
stress. These data identify a nitrosative-stress signaling pathway
that engages ATM and the LKB1 and TSC2 tumor suppressors to
repress mTORC1 and regulate autophagy. As cancer cells are par-
ticularly sensitive to nitrosative stress, these data open another
path for therapies capitalizing on the ability of reactive nitrogen
species to induce autophagy-mediated cell death.
signal transduction | cancer therapy
Autophagy is a self-digestion process by which a eukaryoticcell degrades and recycles aggregate-prone proteins, macro-
molecules, and organelles. During autophagy, cytoplasmic con-
tents are sequestered in double-membrane bound vesicles called
autophagosomes and delivered to lysosomes for degradation,
thereby allowing cells to eliminate and recycle the contents (1–3).
Autophagy participates in both prosurvival (recycling of cel-
lular building blocks) and prodeath (excess catalysis) pathways.
A comprehensive understanding of signaling pathways that reg-
ulate autophagy holds great promise for new therapeutic op-
portunities by opening the possibility to compromise prosurvival
autophagic pathways that enable tumor cells to evade therapy, or
by promoting prodeath autophagic pathways to kill cancer cells.
The classical pathway regulating autophagy in mammalian
cells involves the serine/threonine kinase, mammalian target of
rapamycin (mTOR). Active mTOR kinase in the mTORC1
complex phosphorylates and inhibits ULK1, a key proautophagy
adapter involved in nucleation of the autophagophore mem-
brane. Inactivation of mTORC1, either pharmacologically with
rapamycin or via activation of the tuberous sclerosis complex
(TSC) tumor suppressor, leads to downstream dephosphorylation
events, including loss of ULK1 phosphorylation at S757. The
TSC1/2 heterodimer is itself regulated by upstream kinases, in-
cluding the AMP-activated protein kinase (AMPK), which regu-
lates several metabolic processes and activates the TSC to repress
mTORC1 under conditions of energy stress (4–6). AMPK also
directly regulates autophagy by phosphorylating and activating
ULK1 at S317 (7).
Nitric oxide (NO) is a pleiotropic regulator, critical to nu-
merous biological processes extending from its role as a chemical
messenger and antibacterial agent to an integral component of
the cardiovascular system and immune response to pathogens
(8). NO has also been documented to play both promotional and
inhibitory roles in cancer etiology. NO is produced endogenously
by tumor cells of various histogenetic origins and has been as-
sociated with tumor proliferation and resistance to anticancer
drugs. Although cancer cells may maintain endogenous NO at
elevated levels that facilitate tumor growth, this strategy carries
a survival liability, as high levels of NO can cause cytostasis or
cytotoxicity (9). Thus, cancer cells may be more sensitive to NO-
induced nitrosative stress, which could potentially provide a
therapeutic avenue for modulating nitrosative stress to induce
cell death. However, understanding at the molecular level re-
garding how NO participates in regulation of either prosurvival
or prodeath autophagic pathways is limited.
Recently, a novel signaling pathway involving activation of
ATM to suppress mTORC1 in response to oxidative damage was
identiﬁed (10). In the study reported here, we demonstrate that
NO engages this pathway to suppress mTORC1 and promote
autophagy. In response to nitrosative stress induced by steady-
state exposure to NO, ATM is activated, signaling to AMPK via
LKB1 to activate the TSC tumor suppressor and suppress
mTORC1. Concomitant with suppression of mTORC1, autophagy
is induced, accompanied by loss of cell viability. Our data provide
Signiﬁcance
NO exposure triggered an ATM-mediated damage response in
breast cancer cells involving activation of the LKB1 and TSC2
tumor suppressors, repression of mTORC1, ULK phosphoryla-
tion, and increased autophagic ﬂux. The associated loss of cell
viability indicates that autophagy can function as a cytotoxic
response to nitrosative stress in tumor cells. Collectively, the
data identify a nitrosative-stress signaling pathway that reg-
ulates autophagy. A more comprehensive understanding of
signaling pathways regulating autophagy holds promise for
developing new therapeutic approaches compromising pro-
survival autophagic pathways that enable tumor cells to
evade therapy, or promoting prodeath autophagic pathways
that kill cancer cells.
Author contributions: D.N.T., R.C., L.J.T., C.L.W., and G.N.W. designed research; D.N.T.,
R.C., and L.J.T. performed research; D.N.T., R.C., L.J.T., A.R.T., R.S.S., C.L.W., and G.N.W.
analyzed data; D.N.T., R.C., L.J.T., R.S.S., C.L.W., and G.N.W. wrote the paper; and A.R.T.
developed the model in Fig 5.
The authors declare no conﬂict of interest.
1D.N.T. and R.C. contributed equally to this work.
2To whom correspondence should be addressed. E-mail: wogan@mit.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1307736110/-/DCSupplemental.
www.pnas.org/cgi/doi/10.1073/pnas.1307736110 PNAS Early Edition | 1 of 8
A
PP
LI
ED
BI
O
LO
G
IC
A
L
SC
IE
N
CE
S
PN
A
S
PL
U
S
strong evidence that NO regulates autophagy, with implications
both for understanding the physiological role of NO-induced sig-
naling and the development of therapies that can modulate
nitrosative stress to kill cancer cells.
Results
Steady-State Exposure to Nitric Oxide Decreases Survival of MCF-7
Cells. MCF-7 breast cancer cells were exposed to increasing NO
cumulative doses from 0 to 2,488 μM•min. This dose escalation
was achieved by exposing cells in a reactor to a steady-state
concentration of 11 μM NO for increasing lengths of time from
0 to 280 min. Twenty-four hours postexposure, cells showed
decreased cell viability, compared with untreated controls,
ranging from 27% to 40% after exposure to cumulative doses of
NO from 1,244 μM•min (140 min) to 2,488 μM•min (280 min),
respectively (Fig. 1A). Treatment of control cells with 5%
CO2:21% O2:74% N2 had no effect on cell viability. Importantly,
the following evidence showed that decreased cell viability was
not associated with increased apoptosis or programmed necrosis,
suggesting rather that it was due to alternative cell death path-
way(s): AnnexinV/PI staining and ﬂow cytometry (Fig. 1B);
cleavage of poly (ADP-Ribose) polymerase (PARP, a marker for
apoptosis) (Fig. 1C); and exposures to NO in the presence or
absence of the caspase inhibitor Z-VAD-FMK or the necroptosis
inhibitor necrostatin-1 (Fig. S1 A, B, and C).
Nitric Oxide Suppresses mTORC1 Signaling and Induces Autophagy.
We observed that the same steady-state (11 μM) NO exposure
that induced cell death also suppressed mTORC1 signaling, as
observed by reduced phosphorylation of p70/S6 kinase, 4E-BP1
(S6K and 4E-BP1 are direct targets of the mTOR kinase) and
phosphorylation of S6 (downstream effector target of S6K) (Fig.
2A). Reduction in mTORC1 signaling occurred between 140 and
280 min exposure, at NO doses between 1,244 μM•min (140
min) and 2,488 μM•min (280 min). Comparable results were
obtained when MCF-7 cells were treated with the NO donor
spermine NONOate (SN), which similarly reduced phosphory-
lation of S6K and S6 in a time-dependent manner, with maxi-
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Fig. 1. (A) NO exposure leads to decrease in survival of MCF-7 cells. Cell viability was estimated following NO exposure at a steady-state concentration of
11 μM to attain the cumulative doses (622–2,488 μM•min) presented on the x axis. Cell viability was measured by WST-1 assay 24 h after NO exposure and
expressed as % of control. The data are represented as mean ± SD. (B) Steady-state NO exposure did not increase apoptosis in MCF-7 cells as observed by
annexin-V staining. Emodin at a dose of 20 μM served as a positive control. (C) Western analysis with PARP antibody shows that exposure of MCF-7 cells to NO
is not associated with the activation of PARP. Cells were exposed to NO at a steady-state concentration of 11 μM to attain the cumulative dose of 1,244
μM•min, and lysates were prepared at 0 h, 24 h, 48 h, and 72 h postexposure. Staurosporine at the dose of 1 μM served as a positive control. LE represents
light (short) exposure and DE represents dark (long) exposure of X-ray ﬁlm.
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mum inhibition 2–8 h after treatment and return to baseline at
16 h (Fig. S2A). A similar rebound to baseline was seen after
removal of cells from the NO reactor; suppressed mTORC1
signaling in the presence of NO returned to baseline 8 h after
removal from the reactor and remained at baseline for 24 h
thereafter (Fig. 2B and Fig. S2B).
mTORC1 is a well-known negative regulator of autophagy.
Recent reports indicate that mTORC1 and AMPK have op-
posing effects on autophagy mediated via phosphorylation of
ULK1 at different regulatory sites (7). ULK1 is a key protein
required for nucleation of the autophagophore and formation of
the autophagosome membrane (11). Under optimal growth
conditions, activated mTORC1 inhibits autophagy by direct
phosphorylation of Atg13 and Unc-51-like kinase 1 (ULK1)
at S757. This phosphorylation inhibits ULK1 kinase activity
and subsequent autophagosome formation (12). However, under
conditions of energy stress, AMPK suppresses mTORC1 via TSC
and phosphorylates ULK1 at S317, initiating autophagosome
formation and autophagy. As shown in Fig. 2 B and C, mTORC1
phosphorylation of ULK1 at S757 was inhibited whereas ULK1
phosphorylation at the S317 AMPK site increased in response to
NO exposure. In the NO reactor, these changes in ULK1 phos-
phorylation were induced by exposure to 1,244–2,488 μM•min
NO (Fig. 2C), and 2–4 h after treatment with SN (Fig. S3A).
Concomitant with reduced mTORC1/increased AMPK phos-
phorylation of ULK1, cells were induced to undergo autophagy
as determined using several autophagic markers. Microtubule-
associated protein 1A/1B-light chain 3 (LC3-I), the mammalian
homolog of the yeast protein Atg8 (Aut7/Apg8p), is conjugated
to phosphatidylethanolamine to form LC3-phosphatidyletha-
nolamine conjugate (LC3-II), which is recruited to autophago-
somal membranes (13, 14). Exposure of MCF-7 cells to NO
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Fig. 2. Steady-state NO exposure leads to repression of mTORC1. (A) Western analysis with p-S6K, p-S6, and p-4E-BP1 antibodies shows suppression of
mTORC1 in NO-treated MCF-7 cells. (B) Restoration of mTORC1 activity after NO exposure when cells are incubated in normal culture condition. Time course
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increased the ratios of LC3-II/LC3-I and LC3-II/GAPDH as
determined by western analysis (Fig. 3A), indicative of increased
autophagosome formation in response to mTORC1 repression.
LC3-II to LC3-I ratios and LC3-II to GAPDH ratios remained
elevated 24 h after cells were withdrawn from the NO reactor,
suggesting that NO-induced autophagy persisted in these cells,
possibly due to the continued presence of reactive nitrogen
species formed during NO exposure (Fig. 3B).
To conﬁrm that increased autophagosome formation was due
to increased autophagic ﬂux, cells were treated with Baﬁlomycin
A1 (BafA1), which blocks lysosomal degradation of autolyso-
some contents. Efﬁcacy of this treatment was conﬁrmed by an
increase in LC3-II levels in response to BafA1, with or without
NO treatment (Fig. 3C and Fig. S3B). Similarly, whereas the
long-lived protein and autophagy marker p62 decreased in re-
sponse to NO, treatment with BafA1 abrogated this change,
indicating that decreased p62 was due to increased autophagic
ﬂux as expected (Fig. S3B).
In addition, MCF-7 cells stably transfected with GFP-LC3
exhibited a signiﬁcant increase in punctate cytoplasmic structures
(autophagic vesicles) when treated with NO (Fig. 3D). Autoly-
sosomes are also called acidic vesicles, reﬂecting the presence of
acidic hydrolases that degrade vesicle contents (15). In response
to NO, MCF-7 cells also showed an increase in acridine orange
ﬂuorescence associated with the presence of acidic vesicles and
detected by ﬂow cytometry (Fig. 3E).
Finally, Atg5+/+ (autophagy-proﬁcient) and Atg5−/− (autoph-
agy-deﬁcient) MEFs were used to conﬁrm increased autophagy in
response to NO (16). When cells of both types were treated with
NO, increased LC3-II/LC3I ratio and degradation of p62 oc-
curred only in autophagy-proﬁcient cells (Fig. 3 F and G), in-
dicating dependence on autophagy for the observed responses to
NO. Importantly, Atg5+/+ cells were more sensitive to NO-
induced cell death, exhibiting >70% cell killing in response to low
levels of NO (622 μM•min), compared with autophagy-deﬁcient
cells, in which <20% loss in cell viability was induced by the same
dose (Fig. 3H).
NO Engages the ATM/LKB1/AMPK/TSC Signaling Pathway to Induce
Autophagy. Autophagy is an integral component of cellular
damage responses to many types of stress, including nutrient
deprivation, hypoxia, DNA damage, and oxidative stress. How-
ever, a mechanistic link between nitrosative stress and autophagy
has not been described. Ataxia-telangiectasia mutated (ATM) is
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a key serine/threonine protein kinase that acts as a cellular
damage sensor, coordinating the cell cycle with damage-response
checkpoints and DNA repair machinery to maintain genomic
integrity (17). Several well-known targets for the ATM kinase
include p53 and CHK2, both of which become phosphorylated
in response to reactive oxygen or nitrogen species (10, 18, 19).
Moreover, ATM also functions as a damage sensor in the cytoplasm
via the recently described LKB1/AMPK/TSC pathway (10).
Thus, we explored ATM and this downstream signaling path-
way as a potential mechanism for NO signaling via mTORC1
and AMPK to induce autophagy.
Phosphorylation andactivationofATM(S1981) increased in cells
under conditions of nitrosative stress in both the NO reactor (Figs.
2B and 4A), and in response to SN (Fig. S2C). Phosphorylation of
CT
Hela cells (LKB1 null cells)
Time (min)14070
p-ATM
(S1981)
ATM
p-S6K 
(T389)
p-S6
(S235/236)
S6K
S6
p-4E-BP1 
(T37/46)
4E-BP1
Steady state NO exposure at 11µM
D
p-ATM 
(S1981)
ATM
p-CHK2 
(T68)
CHK2
p-AMPK 
(T172)
AMPK
ACC
GAPDH
p-ACC 
(S79)
Time (min)14070 210 280
Steady state NO exposure at 11µM
000
SN (0.5 mM)
ATM-/- ATM+/- ATM+/+
8 8 8 Time (h)
MEF
ATM
p-S6K 
(T389)
S6K
p-S6
S6
GAPDH
p-4E-BP1 
(T37/46)
4E-BP1
A B C
ATM
p-S6K
(T389)
p-ATM
(S1981)
S6K
p-S6
S6
GAPDH
Time (h)0 4 8 0 4 8
WT-B AT-B
SN (0.5 mM)
E
Steady state NO exposure at 11µM
p-ATM 
(S1981)
ATM
p-S6K 
(T389)
p-S6 
(S235/236)
S6K
TSC2
S6
GAPDH
280CT 140
TSC2+/+ MEF TSC2-/- MEF
280CT 140 Time (min)CT
Fig. 4. Involvement of ATM signaling in mTORC1 repression following NO exposure. (A) Western analysis with p-ATM, p-CHK2, p-AMPK, and p-ACC anti-
bodies and their total protein counterparts shows activation of ATM and downstream effectors in MCF-7 cells exposed to NO. (B) Western analysis of ATM+/+,
ATM+/−, and ATM−/− MEF with p-S6K, p-S6, and p4E-BP1 antibodies shows that repression of mTORC1 by SN is ATM-dependent. (C) Western analysis of EBV-
immortalized B-lymphocytes obtained from an AT (AT-B) patient and nonmutant individuals (WT-B) with p-ATM, p-S6K, and p-S6 antibodies shows that
repression of mTORC1 by SN is ATM-dependent. (D) Western analysis with p-ATM, p-S6K, p-S6, and p4E-BP1antibodies and their total protein counterparts in
HeLa (LKB1-null cells) shows that repression of mTORC1 by NO exposure is LKB1-dependent. (E) Western analysis with p-ATM, p-S6K, and pS6 antibodies in
TSC2+/+ and TSC2−/− MEF shows that repression of mTORC1 by NO exposure is TSC2-dependent. CT, control.
Tripathi et al. PNAS Early Edition | 5 of 8
A
PP
LI
ED
BI
O
LO
G
IC
A
L
SC
IE
N
CE
S
PN
A
S
PL
U
S
Chk2 also increased concomitant with that of ATM, conﬁrming
activation of the ATM kinase (Fig. 4A). Importantly, in ATM-
deﬁcient MEFs (Fig. 4B and Fig. S4A) and ATM-deﬁcient human
lymphoblasts (Fig. 4C), mTORC1 repression and induction of
autophagy in response to NO was greatly attenuated (Fig. 4 B and
C and Fig. S4A). Interestingly, as reported for ROS-induced ac-
tivation ofATM, dependence onATMfor repression ofmTORC1
was lost with adaptation of ATM-null cells to tissue culture (10).
Taken together, these observations indicate thatATMplays a central
role in mTORC1 repression and autophagy induction in response to
nitrosative stress.
When activated by either DNA damage or oxidative stress,
ATM phosphorylates LKB1, the Peutz–Jeghers syndrome tumor
suppressor, at Thr366, activating this kinase and its down-stream
effector, AMPK (10, 20). Commensurate with ATM activation,
we observed LKB1-dependent phosphorylation and activation of
AMPK at T172 by nitrosative stress (Figs. 2B and 4A and Fig.
S3C). AMPK activation was conﬁrmed by phosphorylation of
ACC at S79, a downstream target for the AMPK stress kinase
(Fig. 4A and Fig. S3C). In contrast, as expected, mTORC1 re-
pression and autophagy induction was not observed in LKB1-
null HeLa cells under conditions of nitrosative stress (Fig. 4D
and Fig. S4B). In addition to ACC, raptor was also phosphory-
lated by AMPK (Fig. 2B), suggesting that this inhibitory phos-
phorylation at S792 also contributed to mTORC1 repression.
An important down-stream target of AMPK is the TSC2 tu-
mor suppressor, a “gatekeeper” for mTORC1 signaling that
suppresses mTORC1 in response to energy stress (5, 21). Using
TSC2 proﬁcient (TSC2+/+) and deﬁcient (TSC2−/−) MEFs, we
observed a dependence on TSC2 for mTORC1 repression and
induction of autophagy in response to nitrosative stress (Fig.
S4C). As shown in Fig. 4E, although ATM was activated in re-
sponse to NO in both cell types, mTORC1 repression occurred
only in TSC2-proﬁcient cells, indicating a requirement for TSC2
in this response. Notably, both TSC2+/+ and TSC2−/− MEFs
are p53-deﬁcient, indicating that p53 was not essential for re-
pression of mTORC1 by NO.
The observed repression of mTORC1 and induction of autoph-
agy described above is in contrast to a previous report from
Sarkar et al., who, in 2011, reported that NO donors DETA
NONOate and SIN-1 at high (500 μm) doses induced the op-
posite responses, i.e., activated mTORC1 signaling and re-
pressed autophagy in rat primary cortical neurons and HeLa
cells (22). To investigate these discordant observations, we re-
peated our experiments under the same conditions used by
Sarkar (22), using DETA NONOate as an NO source. HeLa
cells were exposed to the NO donor for 24 h, during which
medium and donor were replenished every 8 h. Under these
conditions, we observed the same increase in mTORC1 signaling
as reported by Sarkar (Fig. S3D). Given that cells were stimu-
lated with medium containing serum every 8 h, we suggest the
following possible explanations for the discordant ﬁndings: (i)
increased nutrient load and activation of mitogenic signaling
pathways stimulated mTORC1 activity, overriding the suppres-
sive effects of NO; (ii) mTORC1 signaling was evaluated only at
24 h; thus, rapid, early effects that we observe at 2–8 h after
treatment with NO donor would be missed; (iii) changing the
medium every 8 h would remove those reactive nitrogen species
formed in response to the NO donor, which are more toxic than
NO itself; and (iv) HeLa cells used for their studies are LKB1-
deﬁcient, which, as we show above, abrogates the ability of ATM to
signal to LKB1 to activate AMPK and TSC to repress mTORC1.
Taken together, our data suggest a model (Fig. 5) whereby
nitrosative stress engages the ATM kinase to activate LKB1,
AMPK, and TSC2. As a result of TSC2 activation, and possibly
direct phosphorylation of raptor by AMPK, mTORC1 is repressed.
The combined loss of (repressive) phosphorylation of ULK1 and
increased (activating) phosphorylation of ULK1 by AMPK results
in increased autophagy and autophagy-mediated cell death in re-
sponse to nitrosative stress.
Discussion
NO is a key signaling molecule that mediates numerous physi-
ological and pathological processes, depending upon concen-
tration, cell type, cellular environment, exposure duration, prox-
imity (intracellular or extracellular), and source. We found that
exogenous exposure to NO rapidly activated ATM kinase, a
damage response protein that recognizes DNA damage in the
nucleus and oxidative damage in the cytoplasm. Activated ATM
signals to AMPK, and we observed a dependence on LKB1 for
activation of AMPK and repression of mTORC1 in response to
NO, as previously reported for ROS (10). Both ROS and RNS
damage DNA and trigger ATM activation to repair this DNA
damage. However, whereas ROS has been shown to activate
cytosolic ATM, additional studies are required to determine
whether nitrosative stress activates ATM in the cytoplasm, nu-
cleus, or both.
At present, the precise biochemical mechanism of activation of
ATM in response to nitrosative stress is not clear. ATM is a very
large protein (∼350 kDa) containing many cysteine residues. Re-
cently, Paull and coworkers reported that, in response to ROS,
ATM is directly activated via oxidation of cysteine residue(s) and
formation of an active ATM homodimer (23). NO may similarly
cause conformational changes in ATM via nitrosylation of sulf-
hydryl or oxidation of sulfhydryl groups by interaction with RNS
reactive intermediates leading to formation of active ATM dimers
(23). However, further work is needed to determine the precise
mechanism of ATM activation in response to nitrosative stress.
In our studies, we used both a reactor in which cells were
exposed to steady-state NO and an NO donor (SN) and observed
mTORC1 repression and induction of autophagy under both
conditions. The role of nitrosative stress in regulating mTORC1
signaling and autophagy has not previously been extensively ex-
plored. We have identiﬁed several kinases, including ATM,
AMPK, and LKB1, that participate in a nitrosative-stress sig-
naling cascade via the tumor suppressors LKB1 and TSC2, which
act to repress mTORC1. Although ATM appears to suppress
mTORC1 via LKB1, AMPK may contribute to mTORC1 re-
pression both directly, by phosphorylating raptor, and indirectly,
via activation of TSC2 (Fig. 5). Our data indicate that the
engagement of the ATM/LKB1/AMPK/TSC2 signaling cascade
by nitrosative stress functions primarily to repress mTORC1 and
induce autophagy.
AMPK 
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RNS 
Lst8 
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Fig. 5. Schematic diagram depicting pathway through which NO and RNS
engage ATM to activate AMPK via LKB1 and repress mTORC1 to modulate
ULK1 activity and induce autophagy.
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Autophagy is a dichotomous phenomenon, involved in cell
survival as well as cell death, depending upon both magnitude
and cell context. Autophagy can promote cell survival by re-
moving old or damaged cellular organelles and recycling key
cellular building blocks for use in required metabolic pathways
and construction of macromolecules. Cancer cells frequently use
autophagy to survive nutrient deprivation induced by therapeutic
agents. However, autophagy above a certain threshold can also
induce cell death and, if triggered appropriately, can be used as
a means of killing cancer cells. Interestingly, our data, showing
that cell viability decreased in the presence of NO and that
ATG5+/+ cells were more sensitive to NO cytotoxicity than
ATG5−/− cells, suggest that autophagy is a prodeath response to
nitrosative stress. Originally designated as type-II programed cell
death, autophagy can be a major death mechanism in cells that
are resistant to apoptosis, as in settings of elevated BCl-2 acti-
vation or caspase-3 deﬁciency (24, 25). Breast cancer cells such
as MCF-7 possess both of these properties and are resistant to
apoptosis (26, 27). If these and other types of cancer cells are
indeed particularly sensitive to induction of autophagy by
nitrosative stress, this sensitivity suggests an opportunity to take
advantage for designing cancer therapies that use nitrosative
stress to induce cancer cell death. Future additional experiments
to characterize the therapeutic index of “nitrosative stress ther-
apy” may yield new insights into how to best exploit this phe-
nomenon to develop more effective cancer therapies.
Materials and Methods
Cell Culture, Antibodies, and Reagents. MCF-7 cells [American Type Culture
Collection (ATCC)] were grown in Improved Modiﬁed Eagle’s Medium (IMEM)
supplemented with 10% (vol/vol) FBS and cultured in a humidiﬁed incubator
at 37 °C with 5% CO2. MCF-7 cells stably expressing GFP-LC3 were maintained
in RPMI 1640 supplemented with 10% (vol/vol) FBS. TSC2+/+ and TSC2−/−Mouse
Embryonic Fibroblasts (MEFs) (kind gifts from Dr. D. Kwiakowski, Harvard
Medical School, Boston, MA) and HeLa cells (ATCC) were grown in MEM
supplemented with 10% FBS. ATM+/+ human lymphoblasts (GM02184) and
ATM−/− human lymphoblasts (GM01526) were acquired fresh (from Coriell
Repositories) for each experiment and maintained in RPMI 1640 supplemented
with 15% FBS for less than four passages in culture. Primary ﬁbroblast ATM+/+,
ATM+/−, and ATM−/− cells derived from embryos at gestation day 13 were
maintained in DMEM media with 15% FBS. Anti-S6K, anti-phospho-S6K
(Thr389), anti-S6, anti-phospho-S6 (Ser235/236), anti-4E-BP1, anti-phospho-4E-
BP1 (Thr37/46), anti-phospho-CHK2 (Thr68), anti-p53, anti-phospho-p53
(Ser15), anti-AMPK, anti-phospho-AMPK (Thr172), anti ACC, anti-phospho-ACC
(Ser79), and anti-LC3 were purchased from Cell Signaling Technologies. Other
antibodies used were anti-ATM (GeneTex), anti-TSC2 (Epitomics), anti-phos-
pho-ATM (Ser1981) (Epitomics), and GAPDH and HRP-conjugated secondary
antibodies were obtained from Santa Cruz Biotechnology. Nitric oxide donor
spermine NONOate was purchased from Cayman Chemical. Caspase Inhibitor
Z-VAD-FMK was purchased from Promega, Necroptotic inhibitor Necrostatin-1,
and Emodin were purchased from SIGMA, and Staurosporine was obtained
from LC Laboratory.
NO Exposure. Cells cultured at a density of 70–80% conﬂuence were plated in
60-mm dishes 24 h before exposure to NO. Using the NO-delivery system
described elsewhere (28, 29), equipped to maintain NO at steady-state
concentration, cells were exposed to 11 μM NO for the indicated time points
to produce the following cumulative doses: 622 μM•min (70 min); 1,244
μM•min (140 min); 1,866 μM•min (210 min); and 2,488 μM•min (280 min).
Cells exposed to 5% CO2:21% O2:74% N2 served as controls. Gases were
purchased from Airgas. Cells were harvested to prepare cell lysates using the
RIPA protocol at various times postexposure (see Immunoblotting).
Treatment with Spermine NONOate and DETA NONOate. MCF-7 cells at ∼70%
conﬂuency were treated with 0.5 mM Spermine NONOate (SN), and lysate
was prepared at different time intervals. Cells were treated with the NO
donor DETA NONOate (DN), for 24 h, during which medium containing fresh
donor compound was replenished every 8 h. For cytotoxicity determination,
MCF-7 cells were treated with 0.5 mM, 1 mM and 2 mM spermine NONOate
with or without caspase inhibitor Z-VAD-FMK (20 μM) or programmed ne-
crosis inhibitor Necrostatin-1 (NEC1, 10 μM). Z-VAD-FMK and NEC1 were
added 1 h before spermine NONOate treatment. After 24 h incubation, cell
viability was performed by WST-1 assay (Roche) as described by manufac-
turer protocol. Emodin at the dose of 20 μM and staurosporine at the dose
of 1 μM serve as a positive control.
NO Exposure and Baﬁlomycin A1 Treatment. Cells were cultured as above. One
hour before exposure to NO, cells were pretreated with 200 nM Baﬁlomycin
A1 in DMSO 3 μL/3 mL or 0.1% DMSO. Treated plates were placed in reactors
that contained IMEM with 200 nM Baﬁlomycin or IMEM with 0.1% DMSO
and treated with NO or 5% CO2:21% O2:74% N2 as a control. Cells were
harvested immediately after exposure, and cell lysates were made using
RIPA protocol (see Immunoblotting).
Cell Viability Analysis. Cell viability was analyzed byWST-1 assay following the
manufacturer’s protocol (Roche). Brieﬂy, coverslips on which 1 × 104 cells
had been were grown overnight in 24-well plates were transferred to spe-
cially modiﬁed NO delivery reactors and exposed to 11 μM NO for speciﬁed
time periods, after which they were transferred to 24-well plates containing
300 μL of fresh medium. After 24 h of incubation, 30 μL of WST-1 per well
was added to the medium followed by incubation for 1 h at 37 °C for 1 h and
measurement of absorbance at 490 nm (Spectra Max Gemini; Molecular
Device). Absorbance directly correlated with the number of metabolically
active cells in the culture, and cell survival was expressed as a percentage of
control cell viability.
Immunoblotting. Following NO exposure, cells were washed twice with PBS
and harvested in RIPA buffer (Sigma-Aldrich) plus 1 mM phenylmethylsulfonyl
ﬂuoride (PMSF), 1 mM sodium orthovanadate (Na3VO4), 1 mM sodium ﬂuo-
ride (NaF), and protease mixture inhibitor. The cells were rocked for 30 min at
4 °C and then centrifuged at 10,000 × g for 10 min. Protein concentrations
were measured by Pierce BCA protein assay kit. Before loading, samples were
mixed with an equal volume of Laemmli Sample Buffer (Bio-Rad), heat
denatured (100 °C, 10 min) with β-mercaptoethanol (β-ME; Sigma-Aldrich),
loaded in precast SDS/PAGE gels (Bio-Rad), transferred to nitrocellulose
membranes, and probed with speciﬁc primary antibodies overnight at 4 °C:
primary antibody p-ATM (S1981) antibody (1:1,000 dilution), ATM antibody
(1:1,000 dilution), p-AMPK (T172) antibody (1:500 dilution), AMPK antibody
(1:500), p-ACC (S-79) antibody (1:1,000 dilution), ACC antibody (1:1,000 di-
lution), p-S6K (T389) antibody (1:500 dilution), S6K antibody (1:500 dilution),
p-S6 (S235/236) antibody (1:2,000 dilution), S6 antibody (1:2,000 dilution),
p-4E-BP-1 (T37/46) antibody (1:2,000 dilution), 4E-BP-1 antibody (1:2,000 di-
lution), p-CHK2 (T68) antibody (1:1,000 dilution), CHK2 antibody (1:1,000 di-
lution), and LC3 antibody (1:1,000 dilution). The following day, they were
probed with secondary anti-mouse or anti-rabbit IgG conjugated horseradish
peroxidase antibody, and chemiluminescence was detected. As a protein
loading control, membranes were stripped and reprobed with GAPDH anti-
body (1:5,000 dilution).
GFP-LC3 Localization. MCF-7 cells stably transfected with GFP-LC3 construct
were plated on coverslips and exposed to nitric oxide in the NO delivery
system. The cells were then ﬁxed in 4% paraformaldehyde for 15min at room
temperature. Coverslips were mounted using Ultra Cruz Mounting Medium
and examined in a Nikon Eclipse E600 ﬂuorescence microscope for presence
of autophagic puncta. The number of puncta per cell was determined and
data were expressed as number of puncta per cell compared with unexposed
GFP positive control or cells exposed to control gas.
Acidic Vesicle Detection. Detection and quantiﬁcation of acidic vesicle for-
mation during the process of autophagy was performed by acridine orange
staining followed by ﬂow cytometric analysis. In brief, MCF-7 cells were
exposed to NO in the delivery system, incubated for 24 h in the incubator,
harvested by trypsinization, washed twice with PBS, and then stained with
acridine orange at a ﬁnal concentration of 1 μg/μL for 30 min in the dark.
Acridine orange is a weak base that can accumulate in acidic compartments,
emitting bright red ﬂuorescence, the intensity of which is proportional to
the degree of acidity and/or volume of the compartment. Samples were
then processed by ﬂow cytometry using blue laser and 620/20 (AO-red) and
530/30 (AO-green) ﬁlters in a C6-Accuri Flow Cytometer.
Detection of Apoptosis. For determination of rate of apoptosis, cells were
cultured as described above and exposed to NO (steady-state 11 μM) for
various lengths of time, followed by 24 h incubation in a humidiﬁed in-
cubator with 5% CO2. Apoptosis was assessed by ApoAlert annexinV-FITC
(ﬂuorescein isothiocyanate) and propidium iodide (PI) apoptosis kit (Clon-
tech) according to the manufacturer’s instructions. Brieﬂy, cells were collected,
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washed with PBS, resuspended in binding buffer provided, and stained with
annexinV (5 μL) and PI (10 μL), and ﬂuorescence was measured on a C6-
Accuri Flow Cytometer.
Detection of PARP. MCF-7 cells were treated as above in the NO delivery
system. Samples and matched controls were harvested at times 0, 24, 48, and
72 h posttreatment as follows. At 0 h, all cells were collected from the reactor
supernatant and PBS washed by centrifugation for 5 min at 1,200 rpm. Lysis
buffer (15 μL) was added to the pellet and added to the lysis buffer re-
covered from the cell culture dish. Samples were then treated as described in
Immunoblotting. Medium and washes collected from time points 24, 48, and
72 h were centrifuged and added to the lysis buffer collected from the cell
culture dishes. In this process, all cells living and dead are collected and
processed for PARP cleavage determination.
Statistical Methods. All data are represented as mean ± SD. The statistical
analysis was performed by SAS statistical software. The quantitative analysis
of Western data was represented as the percentage of fold change from
control. Using this fold-change value, a one-sample, one-sided t test was
performed to determine whether the percent change from control was
higher than 100%. This same method was used for each experiment ex-
amining LC3-II with the respective controls. Similarly, fold change in p62 was
calculated and was analyzed with a one-sample, one-sided t test to de-
termine whether the fold change was less than 100%. The GFP-LC3 puncta
count was compared between control and NO treated group using a one-
sided paired t test. Any P values less than 0.05 were considered statistically
signiﬁcant.
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